Bases de référence des mécanismes et des espoirs thérapeutiques de la bronchite chronique… Les méthodes d'exploration de la fonction muco-ciliaire = Reference of mechanisms and hope in therapeutic of chronic bronchitis… Exploratory methods of the muco-ciliary functionLAFITTE, J. J; COEQUYT, S.NPN médecine. 1988, Vol 8, Num 146, pp 409-412, issn 0248-9635Article

A phase II randomised trial comparing the cisplatin-etoposide combination chemotherapy with or without carboplatin as second-line therapy for small-cell lung cancerSCULIER, J. P; LAFITTE, J. J; KLASTERSKY, J et al.Annals of oncology. 2002, Vol 13, Num 9, pp 1454-1459, issn 0923-7534, 6 p.Article

A randomised phase III trial comparing consolidation treatment with further chemotherapy to chest irradiation in patients with initially unresectable locoregional non-small-cell lung cancer responding to induction chemotherapySCULIER, J. P; PAESMANS, M; MOMMEN, P et al.Annals of oncology. 1999, Vol 10, Num 3, pp 295-303, issn 0923-7534Article

Relationship between a mild α₁ proteinase inhibitor deficiency and respiratory symptoms in a familyHUET-DUVILLIER, G; BALDUYCK, M; WATRIGANT, Y et al.Annals of clinical biochemistry. 1995, Vol 32, pp 545-549, issn 0004-5632, 6Article

Le cancer bronchique à petites cellules, un problème d'actualité en pneumologie = Long small cell epithelioma, a current problem in pneumologyBART, F; LEMONNIER, P; LAFITTE, J. J et al.NPN médecine. 1986, Vol 6, Num 119-120, pp 676-678, issn 0248-9635Article

A phase III randomised trial comparing sequential chemotherapy using cisplatin-based regimen and paclitaxel to cisplatin-based chemotherapy alone in advanced non-small-cell lung cancerSCULIERI, J. P; LAFITTE, J. J; SCHERPEREEL, A et al.Annals of oncology. 2007, Vol 18, Num 6, pp 1037-1042, issn 0923-7534, 6 p.Article

Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysisSTEELS, E; PAESMANS, M; BERGHMANS, T et al.The European respiratory journal. 2001, Vol 18, Num 4, pp 705-719, issn 0903-1936Article

A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancerSCULIER, J. P; PAESMANS, M; ZACHARIAS, C et al.European journal of cancer (1990). 1999, Vol 35, Num 9, pp 1314-1319, issn 0959-8049Article

Secretion and mRNA expression of TNFα and IL-6 in the lungs of pneumoconiosis patientsVANHEE, D; GOSSET, P; MARQUETTE, C. H et al.American journal of respiratory and critical care medicine. 1995, Vol 152, Num 1, pp 298-306, issn 1073-449XConference Paper

Special neutrophil elastase inhibitory activity in BAL fluid from patients with silicosis and asbestosisSCHARFMAN, A; HAYEM, A; DAVRIL, M et al.The European respiratory journal. 1989, Vol 2, Num 8, pp 751-757, issn 0903-1936, 7 p.Article

Functional and immunoreactive α₁ proteinase inhibitor in bronchoalveolar lavages: methodological studiesEL YAMANU, J; HAYEM, A; LAFITTE, J. J et al.Clinical respiratory physiology. 1986, Vol 22, Num 4, pp 359-363, issn 0272-7587Article

Validation and comparison of several published prognostic systems for patients with small cell lung cancerPAESMANS, M; LAFITTE, J. J; VAN HOUTTE, P et al.The European respiratory journal. 2011, Vol 38, Num 3, pp 657-663, issn 0903-1936, 7 p.Article

Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapyBERGHMANS, T; LAFITTE, J. J; WACKENIER, P et al.Lung cancer. 2004, Vol 45, Num 3, pp 339-348, issn 0169-5002, 10 p.Article

A phase II study testing paclitaxel as second-line single agent treatment for patients with advanced non-small cell lung cancer failing after a first-line chemotherapySCULIER, J. P; BERGHMANS, T; LAFITTE, J. J et al.Lung cancer. 2002, Vol 37, Num 1, pp 73-77, issn 0169-5002Article

A three-arm phase III randomised trial comparing combinations of platinum derivatives, ifosfamide and/or gemcitabine in stage IV non-small-cell lung cancerSCULIER, J. P; LAFITTE, J. J; MOMMEN, P et al.Annals of oncology. 2002, Vol 13, Num 6, pp 874-882, issn 0923-7534Article

Role of granulocyte and granulocyte-macrophage colony-stimulating factors in the treatment of small-cell lung cancer: a systematic review of the literature with methodological assessment and meta-analysisBERGHMANS, T; PAESMANS, M; LAFITTE, J. J et al.Lung cancer. 2002, Vol 37, Num 2, pp 115-123, issn 0169-5002Article

The role of mitomycin in the treatment of non-small cell lung cancer: a systematic review with meta-analysis of the literatureSCULIER, J. P; GHISDAL, L; MASCAUX, C et al.British journal of cancer. 2001, Vol 84, Num 9, pp 1150-1155, issn 0007-0920Article

Long-term survivors of small-cell lung cancer (SCLC): A French multicenter studyJACOULET, P; DEPIERRE, A; KLEISBAUER, J. P et al.Annals of oncology. 1997, Vol 8, Num 10, pp 1009-1014, issn 0923-7534Article

Myélome à expression tumorale intrathoracique = Myeloma with intrathoracic tumourBERVAR, J. F; TILLIE-LEBLOND, I; FACON, T et al.Revue des maladies respiratoires. 1995, Vol 12, Num 1, pp 53-55, issn 0761-8425Article

Determinants of response to immunosuppressive therapy in idiopathic pulmonary fibrosisVAN OORTEGEM, K; WALLAERT, B; MARQUETTE, C. H et al.The European respiratory journal. 1994, Vol 7, Num 11, pp 1950-1957, issn 0903-1936Article

Cisplatin and vindesine for siddeminated non-small cell lung cancer. Results of a prospective trial with 81 patientsTOURANI, J. M; PENAUD, D; CAUBARRERE, I et al.Bulletin du cancer. 1990, Vol 77, Num 11, pp 1107-1113, issn 0007-4551, 7 p.Article

Recherche systématique du syndrome de Schwartz-Bartter au cours des cancers bronchiques anaplasiques à petites cellules = Systematic search for the Schwartz Bartter syndrome in small cell anoplasic carcinoma of the lungVANTYGHEM, M. C; SIAME, C; SALOMEZ, F et al.LARC médical. 1986, Vol 6, Num 1, pp 5-8, issn 0242-9462Article

Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): A phase II randomised study by the European Lung Cancer Working PartyBERGHMANS, T; LAFITTE, J. J; SCULIER, J. P et al.Lung cancer. 2012, Vol 77, Num 3, pp 605-610, issn 0169-5002, 6 p.Article

Valproate―doxorubicin: promising therapy for progressing mesothelioma. A phase II studySCHERPEREEL, A; BERGHMANS, T; WILLEMS, L et al.The European respiratory journal. 2011, Vol 37, Num 1, pp 129-135, issn 0903-1936, 7 p.Article

A phase III randomised study of concomitant induction radiochemotherapy testing two modalities of radiosensitisation by cisplatin (standard versus daily) for limited small-cell lung cancerSCULIER, J. P; LAFITTE, J. J; KOUMAKIS, G et al.Annals of oncology. 2008, Vol 19, Num 10, pp 1691-1697, issn 0923-7534, 7 p.Article